History

Find out how two key acquisitions and one of our largest product launches in history helped us enter the neuromodulation field and establish ourselves as a global leader in cardiovascular medicine.
  

Innovaciones Importantes

  
The 2004 launch of this paclitaxel-eluting coronary stent system in the U.S. was one of the largest and most successful product launches in industry history.
  

Crecimiento y adquisiciones

  
The 2006 acquisition of Guidant was the largest in company history, solidifying Boston Scientific as a global leader in cardiovascular medicine. | The 2004 acquisition of Advanced Bionics gave the company entry into the field of neuromodulation.
Arriba